“Budget Impact analysis of the first-line treatment of Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML) adult patients”, FE, vol. 18, no. 1, Jul. 2017, doi: 10.7175/fe.v18i1.1318.